Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk from TAVR

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3hRD9Gz
via IFTTT